Lorena Mata

Lorena Mata

Teaching Assistant I

Followers of Lorena Mata101 followers
location of Lorena MataPittsfield, Massachusetts, United States

Connect with Lorena Mata to Send Message

Connect

Connect with Lorena Mata to Send Message

Connect
  • Timeline

  • About me

    Internal Medicine

  • Education

    • Harvard Medical School

      2021 -
      Certificate Program Foundamentals and applications of Clinical and Translational Research
    • Harvard Medical School

      2014 - 2014
      Certificate program Principles and Practice of Clinical Research
    • Universidad de San Martín de Porres

      -
      Doctor of Medicine (M.D.)
  • Experience

    • Harvard T.H. Chan School of Public Health Center for Executive and Continuing Professional Education

      Feb 2015 - Nov 2015
      Teaching Assistant I
    • Harvard T.H. Chan School of Public Health Center for Executive and Continuing Professional Education

      Feb 2016 - Nov 2016
      Teaching Assistant II
    • Harvard T.H. Chan School of Public Health Center for Executive and Continuing Professional Education

      Feb 2017 - Nov 2018
      Senior Teaching Assistant
    • Research and Teaching Department - Clinica Internacional

      Jun 2020 - now
      Medical Researcher
    • AstraZeneca

      Jun 2020 - now

      Clinical Covid-19 Vaccine Trial:A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Studyin Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non- replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19. Clinical Trial: A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19

      • Co-Investigator

        Oct 2020 - now
      • Co-Investigator

        Jun 2020 - Sept 2020
    • Novartis

      Aug 2020 - Nov 2020
      Co-Investigator

      Clinical Trial: Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess theEfficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm

    • GSK

      Aug 2020 - Jan 2021
      Co-Investigator

      Clinical Trial: A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients with Severe Pulmonary COVID-19 Related Disease

    • Oncotelic

      Feb 2021 - Jul 2021
      Co-Investigator

      Clinical Trial: Double-blind, randomized, placebo-controlled, multicenter study of OT-101 in hospitalized patients with COVID-19

    • Golden Biotechnology Corp (4132)

      Mar 2021 - now
      Co-Investigator
    • BERKSHIRE MEDICAL CENTER - BERKSHIRE CAMPUS

      Jul 2022 - now
      IM resident
  • Licenses & Certifications

    • NIAID Good Clinical Practices

      National Institute of Allergy and Infectious Diseases (NIAID)
      Jul 2021
    • Data Safety and Monitoring Boards

      The Global Health Network
      Jul 2020
    • Good Clinical Practices

      The Global Health Network
      Jul 2020
    • Introduction to clinical research

      The Global Health Network
      Jul 2020
    • Essential Elements of Ethics

      The Global Health Network
      Jul 2020
    • Introduction to Informed Consent

      The Global Health Network
      Jul 2020
    • The Research Question

      The Global Health Network
      Jul 2020
    • The Study protocol

      The Global Health Network
      Jul 2020
  • Honors & Awards

    • Awarded to Lorena Mata
      Association between Interleukin-6 and pulmonary compromise in hospitalized patients due COVID-19 pneumonia Peruvian Pulmonology Society Oct 2020 Pulmonology research award
    • Awarded to Lorena Mata
      Effect of high impact exercise on bone mass density in prepuberal girls: a multicenter, open-label, randomized-controlled trial” Principles and Practice of Clinical Research Sep 2014 Group Project Award
  • Volunteer Experience

    • Medical Volunteer

      Issued by Yantalo Foundation on Nov 2016
      Yantalo FoundationAssociated with Lorena Mata